Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review

Lei Miao, Jing Xu, Giovanni Targher, Christopher D Byrne, Ming-Hua Zheng

Clin Mol Hepatol. 2022;28(4):725-738. Published online March 14, 2022

DOI: https://doi.org/10.3350/cmh.2022.0015

View: 1768 Download: 172 Citation: 1

Original Article

Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcoholic fatty liver disease patients

Wen-Yue Liu, Xiaofang Zhang, Gang Li, Liang-Jie Tang, Pei-Wu Zhu, Rafael S. Rios, Kenneth I. Zheng, Hong-Lei Ma, Xiao-Dong Wang, Qiuwei Pan, Robert J. de Knegt, Luca Valenti, Mohsen Ghanbari, Ming-Hua Zheng

Clin Mol Hepatol. 2022;28(2):183-195. Published online November 28, 2021

DOI: https://doi.org/10.3350/cmh.2021.0301

View: 2340 Download: 168 Citation: 1

Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis

Gang Xu, Yu-Min Wang, Miao-Miao Ying, Sui-Dan Chen, Zong-Rui Li, Hong-Lei Ma, Ming-Hua Zheng, Jian Wu, Chunming Ding

Clin Mol Hepatol. 2021;27(2):329-345. Published online January 20, 2021

DOI: https://doi.org/10.3350/cmh.2020.0261

View: 3608 Download: 184 Citations: 6

1 |

Viewed By 8475	The emerging roles of extracellular vesicles as intercellular messengers in liver physiology and pathology
Viewed By 4756	A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective
Viewed By 3347	Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma
Viewed By 3071	KASL clinical practice guidelines for management of chronic hepatitis B
Viewed By 2642	Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases

Cited By 58	Trends in the prevalence of chronic liver disease in the Korean adult population, 1998–2017
Cited By 50	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 41	Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop
Cited By 39	Novel biomarkers for the management of chronic hepatitis B
Cited By 38	Application of transient elastography in nonalcoholic fatty liver disease

Search